EUVIMEDEUVIMED entdecken
Crossref

Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab

Federico Pravisano, Francesco Cortiula, Amin H Nassar, Martina Bortolot, Andrea Riccardo Filippi, Lorenzo De Marchi, Jessica Saddi, So Yeon Kim, Ritujith Jayakrishnan, Paolo Borghetti, Sarah Debakker, Juliette Degens und 5 weitere

European Journal of Cancer · 2026-12 · 249 · 117811

DOI: 10.1016/j.ejca.2026.117811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-12. Verfasst von Federico Pravisano und 16 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital of Udine, Department of Oncology, Udine, Italy. Electronic address: federico.pravisano@asufc.sanita.fvg.it. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ChemoradiotherapyDurvalumabImmune checkpoint blockadeLocal ablative therapyNon-small cell lung cancerOligoprogressive diseaseSalvage therapyStereotactic body radiotherapy

Autor:innen und Institutionen

  • University Hospital of Udine, Department of Oncology, Udine, Italy. Electronic address: federico.pravisano@asufc.sanita.fvg.it.
  • University Hospital of Udine, Department of Oncology, Udine, Italy; Department of Radiation Oncology (Maastro), Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht…
  • Division of Medical Oncology, Yale Cancer Center, New Haven, CT, USA.
  • Department of Oncology, IRCCS CRO Aviano, Aviano, Italy.
  • Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori and Department of Oncology, University of Milan, Milan, Italy.
  • University Hospital of Udine, Department of Oncology, Udine, Italy.

Zitieren

APA

Pravisano, F., Cortiula, F., Nassar, A. H., Bortolot, M., Filippi, A. R., De Marchi, L., Saddi, J., Kim, S. Y., Jayakrishnan, R., Borghetti, P., Debakker, S., Degens, J., Dursun, S., Macerelli, M., Aprile, G., Hendriks, L. E. L., & De Ruysscher, D. (2026). Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab. European Journal of Cancer, 249, 117811. https://doi.org/10.1016/j.ejca.2026.117811

Vancouver

Pravisano F, Cortiula F, Nassar AH, Bortolot M, Filippi AR, De Marchi L, et al. Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab. European Journal of Cancer. 2026;249:117811. doi:10.1016/j.ejca.2026.117811

BibTeX
@article{Pravisano2026,
  author = {Pravisano, Federico and Cortiula, Francesco and Nassar, Amin H and Bortolot, Martina and Filippi, Andrea Riccardo and De Marchi, Lorenzo and Saddi, Jessica and Kim, So Yeon and Jayakrishnan, Ritujith and Borghetti, Paolo and Debakker, Sarah and Degens, Juliette and Dursun, Safiye and Macerelli, Marianna and Aprile, Giuseppe and Hendriks, Lizza E L and De Ruysscher, Dirk},
  title = {Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {249},
  pages = {117811},
  doi = {10.1016/j.ejca.2026.117811}
}
Kostenlos starten →